The Latin America, Middle East and Africa Vascular Patches Market would witness market growth of 9.1% CAGR during the forecast period (2022-2028).
The qualities of new-generation patches drive late degeneration, and they have long-term stability, durability, easy handling properties, minimal risk of ischemic strokes, and better usage. The demand for these vascular devices has increased as a result of how well they have helped surgeons perform cardiovascular surgeries.
The aforementioned considerations thus have an impact on the market for vascular patches and, therefore, would continue to do so during the upcoming years. The development of novel products and technologies that are suitable for use and for strategic partnerships through technology transfer activities are considerations that favor vascular patch manufacturers to grow their businesses.
This propels the increase in sales growth in addition to the market positioning for leading manufacturers within the vascular patch industry. The development of vascular surgery techniques and the treatment of vascular diseases will be influenced by impending technological developments. Superior medical interventions to halt or even combat atherosclerosis are on the horizon.
According to estimates, non-communicable diseases (NCDs), including CVDs, cause 74% of all adult fatalities in Brazil. Thirty-eight percent (30.8%) of the population suffers from hypertension, which raises the risk of heart failure, heart attack, kidney illness, and stroke. In Brazil, 18.8% of adults are obese, with adult women being more likely to be obese (21.4%) than males (16%). More people are developing type 2 diabetes in Brazil as a result of the country's rising obesity rates; it is estimated approximately 8.8% of females and 7.4% of males have the disease.
The Brazil market dominated the LAMEA Vascular Patches Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $7,755.1 Thousands by 2028. The Argentina market is experiencing a CAGR of 9.7% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 8.8% during (2022 - 2028).
Based on Material, the market is segmented into Biologic and Synthetic. Based on End User, the market is segmented into Hospitals and Ambulatory Surgical Centers. Based on Application, the market is segmented into Carotid Endarterectomy, Open Repair of Abdominal Aortic Aneurysm, Vascular Bypass Surgery, Congenital Heart Disease and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Vascular Patches Market is Predict to reach $529 Million by 2028, at a CAGR of 7.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Edwards Lifesciences Corporation, Baxter International, Inc., Lemaitre Vascular, Inc., Becton, Dickinson and Company, Terumo Corporation, Aziyo Biologics, Inc., Getinge AB, B. Braun Melsungen AG, Artivion, Inc. (CryoLife, Inc.), and W. L. Gore & Associates, Inc.
By Material
By End User
By Application
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 